SESSIONS OVERVIEW
HALL A
(CLINICAL COMMUNICATIONS)
08:00-08:30 REGISTRATION
08:30-10:00 INAUGURAL SESSION:(AMPHITHEATER)
Pr. Jean Marc Ayoubi (FR), Pr. Botros Rizk (USA)
KEYNOTE LECTURE
Samir Hamamah (FR) - Worldwide strategy for fighting infertility
10:30-12:00 SESSION 1A:INFERTILITY–PREVALENCE AND ETHNICITY
Chair:PE. Bouet*
Hassan Salam (EG) - The changing Face of assistance reproduction from rock-start doctors to bland Brands.
Luigi Montano (IT) - Environmental Impact on Fertility. The EcoFoodFertility Research Project: A Study Model for Polluted Areas of the World
Minguez Alarcon, Lidia (US) - Chemical and Non-Chemical Stressors and Infertility Treatment Outcomes
12:00-13:00 SESSION 2A:INNOVATION AND RIGHT TO ACCESS THE ART
Chairs:Sofiane Bendifallah, Samir Hamamah (FR)
Johnny S. Younis (IL) - The Pros and Cons of Endometriotic Cystectomy in the Reproductive Age: A Critical Appraisal of the Quality of Evidence ​
​
13:00-14:00 SYMPOSIUM–ART:COST AND EFFICIENCY
Thomas D’Hooghe (DE) - Guidelines for IVF Centers to Provide High Quality Data for Real World Data Research
14:00-15:00 SESSION 3A:ENDOMETRIOSIS
Chair:
Antonio D’Amato (IT) - Can the Addition of Corticosteroid to Antibiotic Therapy for Chronic Endometritis in Women with Recurrent Implantation Failure Improve Their Reproductive Outcomes?
Sofiane Bendifallah (FR) - Non-Invasive Test for Early Diagnosis
15:00-18:00 SESSION 4A:POOR OVARIAN RESPONSE-PREDICTORS AND MANAGEMENT
Chair:Fréderic Lamazou* (FR)
Peter Kovacs (HU) - Should We Consider ‘Milder’ Stimulation for Poor Responders Undergoing IVF?
Hassan Sallam (EG) - Can We Really Use Ovarian Reserve Markers As A Guide to Ovarian Stimulation?
Aref Maddahi (IR) - Evaluvation of Various Drugs in the Treatment of Fertility Due to Poor Ovarian Reserve
Thomas D’Hooghe (DE) - Beyond FORT and FOI: New Key Performance Indicators to Assess Efficiency of Ovarian Stimulation for ART in Women with Poor Ovarian Reserve ( Alternative Title: Added Value of rFSH : rLH Cotreatment in Poor Ovarian Responders: What is the Evidence? )
Yassir Ait benkaddour (MAR) - Conventional Controlled Ovarian Stimulation - Protocols for Diminished Ovarian Reserve
Patients and Poor Responders
HALL B
(CLINICAL COMMUNICATIONS)
​10:30-11:30 SESSION 1B:POLYCYSTIC OVARY SYNDROME(PCOS)
Chairs:Anne Bachelot*, Sophie Christin Maître*
Christine Decanter (FR) - PCOS in IVF: How to Stimulate? Strong or Soft?
Abbara Ali (UK) - Kisspeptin and Infertility​
11:30-12:30 SESSION 2B:WHAT CONTROL ON OVARIAN STIMULATION PROTOCOLS Chairs:Nathalie Massin*, Sophie Christin Maitre*
Nathalie Massin* (FR) - Place of AI in ART
Bouchra El Amiri (MAR) - Exploring Endogenous and Exogenous Factors for Successful Artificial Insemination in Sheep: A Global Overview
12:30-13:00 SYMPOSIUM/LUNCH
14:00-16:00 SESSION 3B:MEDICAL AND EMBRYOLOGICAL QUALITY IN IVF CENTERS
Chair:Marine Poulain*
Waleed Marei (BE) - Safegarding Embryo Quality and Offspring Health: Lessons From Humans’ Studies and
Pathophysiological Animal Models
AÅŸina Bayram (UAE) - Which Variabled Have An Impact on the Clinical Pregnancy Rate?
Stephane Viville (FR) - Genetics of Infertility: A Paradigm Shift for Medically Assisted Reproduction
Marine Poulain (Fr) - Child Health Issued From ART
16:30-18:00 SESSION 4B:UP TO DATE DIAGNOSIS OF INFERTILITY
Chair:Marie Carbonel*
Celia Ravel (FR) - Ovarian Extracellular Vesicles: New Markers of Female Fertility
Christine Decanter (FR) - Clinical Utility of AMH Measurement in Reproductive Medicine
Barbara Lawrenz (UAE) - Luteal Phase Stimulations: the Good, the Bad and the Ugly
